Gait in Huntington's disease and the stride length-cadence relationship

BMC Neurology
|October 1, 2014
PubMed

Insights

Gait control is disrupted in Huntington's disease (HD), specifically stride length scaling, but cadence regulation remains intact. This research clarifies gait abnormalities in HD patients.

Area of Science:

  • Neuroscience
  • Biomechanical Engineering
  • Movement Science

Background:

  • Huntington's disease (HD) causes progressive gait deterioration, impacting function.
  • Gait control mechanisms, particularly stride length and cadence relationships, are altered in neurological disorders.
  • Understanding these changes is crucial for managing HD progression.

Purpose of the Study:

  • To investigate the automatic control of gait in Huntington's disease (HD) by analyzing the stride length-cadence relationship.
  • To compare gait control mechanisms between individuals with HD, Parkinson's disease (PD), and healthy older adults (HOA).

Main Methods:

  • Compared stride length-cadence relationships in 17 HD, 20 PD, and 21 HOA participants.
  • Recorded gait at various speeds (preferred, slow, fast).
  • Used linear regression to analyze slope and intercept, comparing adjustments in stride length and cadence across speeds and groups.

Main Results:

  • Stride length was significantly shorter in HD and PD groups compared to controls.
  • Intercept of the stride length-cadence relationship was lower in HD and PD groups.
  • Cadence and its adjustment across speeds did not differ between groups, indicating preserved cadence regulation.

Conclusions:

  • Stride length scaling is disrupted in individuals with Huntington's disease.
  • Cadence regulation during gait is preserved in HD, unlike stride length.
  • Findings highlight specific gait control deficits in HD, differentiating it from other movement disorders.
Abstract